Despite effective administration of combination antiretroviral therapy to human immunodeficiency virus type 1 (HIV-1)-infected pregnant women, mother-to-child transmission (MTCT) of HIV-1 remains a significant global public health concern. Several copathogens that pose threats to the developing fetus during gestation, such as cytomegalovirus (CMV), malaria parasites, and Mycobacterium tuberculosis, may also facilitate in utero transmission of HIV-1 and contribute to the high incidence of MTCT within specific populations [1] [2] [3] . These pathogens can promote transmission through increases in proviral load, immune activation, local inflammation, and maternal stimulation of fetal CD4 + cells to increase cellular susceptibility to HIV-1 infection. CMV, a highly prevalent beta herpesvirus, infects >90% and 50%-80% of reproductive-age women in developing and developed countries, respectively. HIV-1-infected infants who acquire CMV infection in the first 18 months of life have a significantly higher rate of disease progression than those infected with HIV-1 alone [4, 5] . Studies have shown that CMV induces increases in T-cell activation in peripheral blood mononuclear cells (PBMCs) from HIV-1-infected infants [6] and memory cell differentiation [7] . Strong associations between in utero CMV infection and a higher incidence of MTCT of HIV-1 have been documented [8, 9] ; however, the mechanisms that increase neonatal HIV-1 transmission remain unknown. Several in vitro studies demonstrate increased viral transcription and replication in phytohemagglutinin (PHA)/interleukin 2 (IL-2)-activated cord blood mononuclear cells (CBMCs), compared with adult PBMCs. However, these conditions do not mimic the in utero environment, which is normally immunoquiescent and associated with a low risk of HIV-1 transmission (7%) in vivo.
In contrast, immune activation may facilitate HIV-1 infection following in utero exposure to CMV antigens. Increased T-cell activation may be associated with CCR5 expression and susceptibility of CBMCs to HIV-1. The goal of the current study is to examine the targets and mechanisms that affect fetal susceptibility to HIV-1 in utero. We demonstrate that the fraction of CD4 + CCR5 + and CD4 + CD45RO + T cells in cord blood is significantly lower, compared with adult PBMCs, which may reflect that the low level of in utero HIV-1 transmission is due to a lack of target cells. 
METHODS

Ethics Statement
With written informed consent, umbilical cord blood specimens were collected from 15 women (age, >18 years) seronegative for HIV-1, CMV, and hepatitis B virus following cesarean section without labor (gestation, >37 weeks) at Emory Midtown Hospital (Atlanta, GA). Approval of the study was granted from the Emory University Institutional Review Board (IRB). Peripheral blood specimens were obtained from healthy adult volunteer donors according to a protocol approved by the Emory University IRB.
Isolation and Stimulation of Mononuclear Cells
CBMCs and PBMCs were separated from heparinized wholeblood samples by density gradient centrifugation on FicollHypaque (Sigma Chemical Co., St. Louis, MO) and maintained in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum, 1 mM L-glutamine, and 1% pen/strep (Mediatech, Manassas, VA). CBMCs and PBMCs were stimulated with PHA (5 µg/mL) and IL-2 (5%) in the complete medium. CD4 + T cells were purified from isolated mononuclear cells by negative selection, using the CD4 isolation kit (Miltenyi Biotec, Auburn, CA) according to the manufacturer's protocol, yielding an average purity of ≥96%. To isolate macrophages, monocytes were then enriched from PBMCs by use of the MACS Monocyte Isolation Kit II and MACS LS Columns (Miltenyi), yielding an average purity of 98%. Monocytes were suspended in RPMI medium containing pen/strep (1%), glutamine (1%), and heat-inactivated normal human serum (10%; Mediatech); seeded into 24-well plates; and cultivated for 7 additional days to promote full differentiation into macrophages.
HIV-1 Infection of PBMCs and CBMCs
PBMCs and CBMCs were infected at 0.5 50% tissue culture infective doses (TCID 50 ) per cell for 4 hours at 37°C with HIV-1 BaL . The TCID 50 values were calculated according to the method of Reed and Muench [2] . The HIV-1 BaL strain is R5 trophic and was initially isolated from infant lung tissue [10] . To monitor viral production, cell supernatants were collected at various days after infection. Viral replication was measured using enzyme-linked immunosorbent assay to detect p24 released into the supernatant (Advanced BioScience Laboratories, Rockville, MD).
Real-Time Polymerase Chain Reaction (PCR)
Messenger RNA (mRNA) was extracted using the RNAeasy kit (Qiagen, Valencia, CA). The complementary DNA was transcribed using QuantiTect RT kit (Qiagen). The primer sequences were as follows: env, forward primer 5′-GGGGACCAGGGA GAGCATT-3′ and reverse primer 5′-TGGGTCCCCTCCTGA GGA-3′; gag, forward primer 5′-ACATCAAGCAGCCATGC AAAT-3′ and reverse primer 5′-ATCTGGCCTGGTGCAATA GG-3′); cxcr4 forward primer 5′-TGACTCCATGAAGGAA CCCTG-3′ and reverse primer 5′-CTTGGCCTCTGACTGTT GGTG-3′; ccr5, forward primer 5′-AATAATTGCAGTAGCT CTAACAGG-3′ and reverse primer 5′-TTGAGTCCGTGTCA CAAGCCC-3′; and β-actin forward primer 5′-GGCCCAGT CCTCTCCCAAGTCCAC-3′ and reverse primer 5′-GGT AAGCCCTGGCTGCCTCCACC-3′. Real-time PCR was performed using SYBR Green (Qiagen). All reactions were run in triplicate, using the Applied Biosystems Prism 7500 Sequence Detection System. Delta threshold cycle (Ct) values from the calibrator and experimental groups were measured by subtracting the Ct value of the target from that of the housekeeping transcript, β-actin.
Flow Cytometry
Staining for flow cytometry studies was performed using monoclonal antibodies that are cross-reactive with PBMCs and CBMCs. One million cells were labeled with the following antibodies: anti-CD3 (A700), anti-CD4 (PerCp-Cy5.5), anti-CD8 (PE-Cy7), anti-CD45RO (APC), anti-CD27 (PE), anti-Ki67 (V450), anti-CD38 (PE-Cy5), anti-HLADR (APC-H7), CXCR4 (PE-Cy5), and anti-CCR5 (PE-CF594; BD Biosciences, CA). Detection of intracellular HIV-1 capsid p24 antigen was performed using KC57 monoclonal antibody (Coulter, Barcelona, Spain). Samples were processed on a BD LSR II flow cytometer, and analysis of the data was performed using FlowJo software (Tree Star). Cell frequencies were calculated as the percentage of cells with a fluorescence intensity greater than that of the fluorescence minus one (FMO) gate. 
CMV Infection and Coculture Experiments
Statistical Analysis
Parametric data were analyzed by using Student t test (2-tailed) to assess whether the mean values for 2 normally distributed groups differed significantly. All nonparametric data were analyzed using the Mann-Whitney U Test. All error bars represent the standard error (±SE).
RESULTS
Unstimulated CBMCs Have Reduced Ability to Replicate HIV-1
Several studies have demonstrated increased HIV-1 replication in PHA/IL-2-activated CBMCs, compared with adult PBMCs, but conditions in these studies do not mimic the in utero environment, which is typically an immunoquiescent milieu. To determine the ability of fetal blood to replicate HIV-1, we compared viral replication in unstimulated CBMCs to that in PHA/IL-2-stimulated cells, using HIV-1 BaL at a TCID 50 of 0.5 per cell. p24 was detected over time in supernatant fluid, compared with their stimulated counterparts. Mean production of p24 antigen in unstimulated cells was greatly reduced, compared with that detected in PHA/IL-2-stimulated CBMCs cultured in parallel at the same TCID 50 ( Figure 1A ). To further account for the reduced ability of unstimulated CBMCs to replicate HIV-1, we monitored viral gene transcription 6 days after infection, using real-time PCR. We found that unstimulated CBMCs showed mean fold-decreases (±SE) of 4.7 ± 0.6 in gag mRNA (average Ct values) and 24 ± 4.3 in env mRNA, compared with PHA/ IL-2-stimulated cells ( Figure 1B ). In contrast, stimulation had minimal effects on viral transcription in adult PBMCs. Combined, these results demonstrate that stimulated CBMCs have a markedly increased sensitivity to HIV-1 infection, while unstimulated CBMCs limit viral replication of HIV-1 BaL in vitro.
CBMCs Have a Lower Fraction of CD45RO + Memory T Cells, Compared With PBMCs
Previous studies have noted a paucity of CD4 + T cells with a memory phenotype in infants and children. In neonates, we investigated this further by first comparing the percentage of naive (T N ), T CM , and effector memory (T EM ) subsets among CD3 + CD4 + T cells in cord blood samples derived from HIV-1-uninfected newborns and peripheral blood samples from HIV-1-uninfected healthy adults. Cell surface markers were used to divide the CD3 + CD4 + T-cell populations into
, and T EM (CD45RO + CD27 − ) subsets, as previously described [11] [12] [13] . The majority of cord blood lymphocytes have a naive phenotype and express minimal levels of CD45RO ( Figure 2A ). We also noted a significantly lower fraction of both memory subsets in CD4 + CBMCs, compared with PBMCs ( Figure 2B ). These findings may reflect relatively limited exposure to foreign antigens in utero in uncomplicated pregnancies [14] and corroborate previous data demonstrating a paucity of T cells with the memory phenotype in infants and children [15] . To investigate how in vitro activation affects the fraction of memory cells in CBMCs, we assessed the percentage of T N and T CM in cells that were stimulated with the mitogens PHA/IL-2. We found that the percentage of T CM cells was significantly upregulated in CBMCs and PBMCs ( Figure 2B ). No differences were noted in the T EM fraction of the CBMCs, while stimulation induced a significant decrease of the T EM cells in adult PBMCs. In cord blood, the T CM fraction was significantly upregulated in PHA/IL-2-stimulated cells (P < .0001), compared with unstimulated CBMCs ( Figure 2C ). and adult blood proliferated and became activated to a similar extent after stimulation, as determined by the expression of Ki67 ( Figure 3A ), a cellular marker for proliferation, and the activation marker CD38 ( Figure 6A ). In addition, CD4 + CXCR4 + T cells were equivalent in CBMCs and PBMCs before and after stimulation ( Figure 3B ). In contrast, the fraction of CD4 + T cells expressing CCR5 was significantly lower in the CBMCs at baseline, compared with the PBMCs (P < .0001). Following stimulation with PHA/IL-2, the fraction of cord blood CD4 + CCR5 + T cells increased such that, by day 4, CCR5 levels were significantly elevated, compared with the unstimulated cells (P < .0001), and that, by day 6, CCR5 levels were similar to those noted in stimulated adult PBMCs ( Figure 3B and 3C ). To determine whether this low level of CCR5 expression by CBMCs at baseline and following in vitro stimulation was associated with an increase in CCR5 transcription, we assessed CCR5 and CXCR4 mRNA expression in purified CD4 T cells obtained from cord and adult blood specimens 24 hours after stimulation with PHA/IL-2. Following treatment, we found that stimulated CBMCs showed a mean fold-increase (±SE) of 9.25 ± 1.9 in CCR5 mRNA expression (average Ct values) and a mean fold-decrease of 0.15 in CXCR4 mRNA expression. In contrast, PBMCs showed an increase in mRNA expression of both chemokine receptors. These results suggest that CCR5 expression may be upregulated in neonates in response to stimuli, which could increase susceptibility to HIV-1. leads to upregulation of CCR5 in T CM cells, which greatly increases their susceptibility to HIV-1.
CCR5 Expression Upon In Vitro Stimulation and Proliferation Is
CBMCs Primed With CMV Upregulate CCR5 Expression on T CM CD4 + Cells
Next we determined how CMV affects CCR5 expression of CD4 + T cells isolated from cord and adult blood specimens.
Cells were cocultured with CMV-infected adult macrophages for 4 days in the absence of other mitogenic stimulation. Treatment of CBMCs with CMV antigens resulted in a moderate increase of CD4 + proliferation in both cord and adult cells, but a dramatic increase in the T CM population was noted, compared with control CBMCs cocultured with uninfected macrophages (increase, approximately 8-fold; Figure 5A ). In addition, the T CM subset in the CMV-experienced CBMCs expressed high percentages of CCR5 after in vitro stimulation. Unlike the PHA/IL-2 group, CMV treatment appears to upregulate CCR5 expression on both naive and memory subsets ( Figure 5B ).
Expression of Activation Markers on T CM CBMCs May Correlate With HIV-1 Susceptibility
We further examined the role of CMV priming on immune activation by evaluating whether T N and T CM from CMV-primed and/or PHA/IL-2-treated CBMCs showed increased activation as measured by CD38 and HLA-DR expression. We found that the control groups maintained consistently lower levels of CD38 in both groups. In contrast, stimulation with CMV and PHA/ IL-2 induced upregulation of CD38 + cells in T N and T CM subsets. Coexpression of CD38 and HLA-DR was lower for the T N cells, compared with control, and was slightly increased in the T CM subset ( Figure 6A ). Taken together, these findings indicate that CBMCs become activated following stimulation of CMV antigen. To investigate whether CMV priming is associated with greater susceptibility to HIV-1 infection, we compared viral replication in purified CD4 + CBMCs cocultured with CMVinfected macrophages, uninfected macrophages, or PHA/IL-2, using HIV-1 BaL at a TCID 50 of 0.5 per cell. p24 fluid was detected in supernatant over time. Mean production of p24 antigen in CBMCs cocultured with CMV-infected macrophages was significantly elevated over time, compared with production in control CBMCs cultured in parallel ( Figure 6B) . Interestingly, the replication kinetics of CBMCs primed with CMV was more robust than that for the PHA-IL-2-treated cells. In addition, we monitored viral gene transcription 6 days after infection, using real-time PCR. We found that CMV antigen-experienced cells exhibited mean fold-increases (±SE) of 607.57 ± 125.63 in gag mRNA (average Ct values) and 421.4 ± 117.75in env mRNA, compared with unstimulated cells (Figure 6C ).
Collectively, these results demonstrate that priming CBMCs with CMV may render these cells more susceptible to HIV-1 infection in vitro.
DISCUSSION
The risk of in utero transmission is <7%. Therefore, even in the absence of virologic suppression with maternal antiretroviral therapy, >90% of HIV-1-exposed newborns are naturally protected from infection in utero. In addition, cases of transient HIV-1 infection in infants, defined as detection of HIV-1 in 1 or more peripheral blood specimen from an exposed infant followed by no detection of HIV-1 in a subsequent specimen, have been reported [17] [18] [19] . These observations suggest that the developing fetus and neonate may restrict establishment of lentiviral infection and viral latency in resting CD4 + CD45RO
+ memory cells, which may reflect a lack of antigenic exposure in utero and during infancy. In peripheral blood, CD4 + CD45RO + memory cells were found to be major in vivo targets of infection by R5-trophic HIV-1 [20, 21] . Here we showed a paucity of memory cells in CBMCs and reduced expression of CCR5. Furthermore, in vitro studies show that CD4 + T cells from cord blood must be activated prior to infection with HIV-1. This suggests that the neonatal immune system is immunoquiescent and that a reduced number of target cells may limit vertical transmission of HIV-1.
Neonates have higher rates of morbidity and mortality from infectious diseases than adults, owing to their increased susceptibility to infection and their increased risk of disease progression. This intrinsic susceptibility to pathogens has been related to the immaturity of the neonatal immune system. Several studies have shown that neonatal T cells have reduced proliferative capacity in response to stimulation and limited cytotoxic activity [22] . However, in the presence of strong costimulatory signals, neonatal CD4 + and CD8 + T cells capable of adult-level responses have been reported [23] [24] [25] . A potential mechanism of fetal activation leading to increased viral susceptibility is by upregulation of CCR5, thereby facilitating viral entry [26] . Preferential R5 virus replication in memory cells was associated with higher CCR5 expression than in naive cells. Here we showed that stimulation of CBMCs with PHA/ IL-2 induced a dramatic increase in CCR5 expression, particularly in CD4 + T CM CBMCs. In addition, stimulated CD4 Previous studies have shown that cord blood T cells can respond to endogenous antigens, minor histocompatibility antigens that are disparate between mother and fetus, and viral antigens if the mother is seropositive or vaccinated [27] [28] [29] . Therefore, antigens in the maternal environment may prime fetal cells transplacentally to elicit antigen-specific T-cell responses. Maternal infections with potential pathogens such as CMV, malaria parasites, and M. tuberculosis may influence the risk of MTCT of HIV-1. Previous studies documented that CBMCs from 50% of malaria-sensitized Kenyan infants were capable of being productively infected with HIV-1 in vitro without prior exogenous stimulation [1] . Other studies demonstrated that maternal tuberculosis is associated with increased immune activation and HIV-1 replication in infant T cells [3] . Initial reports dating back to 1989 demonstrated correlations between CMV infection and rapid progression to AIDS [30] . More recently, a strong association has been noted between maternal HIV-1 and congenital CMV infection in populations in sub-Saharan Africa where the seroprevalence of HIV-1 and CMV are high [9] . In addition, congenital and postnatal CMV acquisition are independent correlates of vertical transmission of HIV-1 [31] . Despite the immaturity of the neonatal immune system, fetuses infected in utero with CMV develop a mature and functional CD8 + T-cell response, similar to that detected in adults [23, 32] . During the acute phase of infection, these differentiated cells have a central memory phenotype. Several studies that noted preponderant CD8 + T-cell responses in antigen-primed cord blood also detected CMVspecific CD4 + responses in CBMCs from congenitally infected newborns.
The goal of the current study was to examine the targets and mechanisms that affect fetal susceptibility to HIV-1 in utero. We developed an in vitro model to examine how naive cord blood T cells might respond to CMV antigens through allopriming with CMV-infected macrophages. Macrophages have been shown to play an important role in initiating primary T-cell responses and are involved in the regulation of CMV latency and reactivation [33, 34] . We found that stimulation with CMV antigens led to an approximately 10-fold increase in T CM cells. These cells showed evidence of T-cell activation, along with steady increases in CCR5 expression over time. Activated T lymphocytes with increased CCR5 expression are strongly implicated in HIV-1 acquisition and disease progression [35, 36] [38] . Furthermore, recent studies have demonstrated that infected memory T cells that survive the apoptotic effects of the virus may return to a resting state and serve as a latent reservoir of HIV-1 in vivo [39] . In this regard, novel studies have reported that when R5-tropic HIV-1 abortively infects nonpermissive, quiescent CD4 + T cells from lymphoid tissue, these cells die by pyroptosis, an intensely inflammatory form of programmed cell death [40, 41] . This was shown to be particularly prominent within the CD4 + CCR5 MTCT observed in utero. However, infants born to mothers coinfected with CMV may be primed by viral antigens so that subsequent activation and upregulation of CCR5 in T CM CBMCs could increase the risk of vertical transmission of HIV-1. Understanding host factors that increase HIV-1 susceptibility is essential to devise novel therapies for viral eradication.
Notes
